A New Jersey-based pharmaceutical company has registered to operate in Montana, according to records filed with the Montana Secretary of State's office. Averitas Pharma, Inc., headquartered at 360 Mount Kemble Avenue in Morristown, N.J., filed as a foreign profit corporation in the state.

The company is associated with Qutenza, a prescription patch that uses capsaicin — the compound responsible for the heat in chili peppers — as an active ingredient for treating certain types of nerve pain. The product is designed as a drug-in-adhesive patch used in pain management settings. Academic researchers have disclosed receiving research support from Averitas Pharma in connection with the product, indicating the company is active in funding clinical and academic work.

Details about Averitas Pharma's specific plans in Montana were not included in the registration filing. Registering as a foreign corporation is standard practice for pharmaceutical companies that must file in each state where they intend to market or distribute products. Residents seeking more information about the company's Montana operations can contact the Montana Secretary of State's office.